clinical trial · NCT06979973
A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants
HealthyMidazolamRosuvastatinCKD-508 Tablet
brief summary
Phase 1, open-label, non-randomized, three-treatment, one-sequence interaction study to evaluate the PK interactions between CKD-508, midazolam, and rosuvastatin in healthy adult male participants
started
May 14, 2025
primary completion
Aug 17, 2025
completion
Aug 17, 2025
last updated
Feb 27, 2026
official title
A Phase 1, Open-label, Drug-Drug Interaction Study to Assess the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participants
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol